Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1

Virology

Volumn 239, Issue 2, 1997, Pages 315-326

  Morrison, Lynda A ^a   Knipe, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANTIBODY TITER; ARTICLE; COMMON COLD; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOPATHOLOGY; KERATITIS; PRIORITY JOURNAL; PROGENY; T LYMPHOCYTE SUBPOPULATION; VIRUS ENCEPHALITIS; VIRUS REPLICATION;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; RNA VIRUSES;

EID: 0031583815     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8884     Document Type: Article

References (50)

1. Guide for the Care and Use of Laboratory Animals. 1985;National Institutes of Health.
2. Atherton S. S. Protection from retinal necrosis by passive transfer of monoclonal antibody specific for herpes simplex virus glycoprotein D. Curr. Eye Res. 11:1992;45-52.
3. Augenbraun M., Feldman J., Chirgwin K., Zenilman J., Clarke L., DeHovitz J., Landesman S., Minkoff H. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann. Int. Med. 123:1995;845-847.
4. Avery A. C., Zhao Z. S., Rodriguez A., Bikoff E. K., Soheilian M., Foster C. S., Cantor H. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature. 376:1995;431-434.
5. Babu J. S., Kanangat S., Rouse B. T. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J. Immunol. 154:1995;4822-4829.
6. +. J. Virol. 71:1997;3534-3544.
7. Brubaker J. O., Thompson C. M., Morrison L. A., Knipe D. M., Siber G. R., Finberg R. W. Induction of Th1-associated immune responses to beta-galactosidase expressed by a replication-defective mutant of herpes simplex virus 1. J. Immunol. 157:1996;1598-1604.
8. Burke R. L. Contemporary approaches to vaccination against herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:1992;137-158.
9. Cook M. L., Stevens J. G. Latent herpetic infections following experimental viraemia. J. Gen. Virol. 31:1976;75-80.
10. Da Costa X. J., Bourne N., Stanberry L. R., Knipe D. M. Construction and characterization of a replication-defective HSV-2. Virology. 232:1997;1-12.
11. +. Clin. Immunol. Immunopathol. 61:1991;398-409.
12. El-Asrar A. M., Geboes K., Missotten L., Emarah M. H., Desmet V. Expression of MHC class II antigens and immunoglobulin M by the corneal epithelial cells in herpetic keratitis. Int. Ophthalmol. 14:1990;233-239.
13. Farrell H. E., McLean C. S., Harley C., Efstathiou S., Inglis S., McLean A. C. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J. Virol. 68:1994;927-932.
14. Gao M., Knipe D. M. Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein. J. Virol. 63:1989;5258-5267.
15. Gao M., Knipe D. M. Potential role for herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression. J. Virol. 65:1991;2666-2675.
16. Ghiasi H., Wechsler S. L., Kaiwar R., Nesburn A. B., Hofman F. M. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J. Virol. 69:1995;334-340.
17. Hendricks R. L., Tumpey T. M., Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149:1992;3023-3028.
18. Hoggan M. D., Roizman B. The isolation and properties of a variant of herpes simplex producing multinucleated giant cells in monolayer cultures in the presence of antibody. Am. J. Hyg. 70:1959;208-219.
19. Jiang H., Zhang S. I., Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science. 256:1992;1213-1215.
20. Klein R. J. Effect of immune serum on the establishment of herpes simplex virus infection of trigeminal ganglia of hairless mice. J. Gen. Virol. 49:1980;401-405.
21. Knipe D. M., Quinlan M. P., Spang A. E. Characterization of two conformational forms of the major DNA-binding protein encoded by herpes simplex virus 1. J. Virol. 44:1982;736-741.
22. Knipe D. M., Spang A. E. Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus. J. Virol. 43:1982;314-324.
23. Lausch R. N., Oakes J. E., Metcalf J. F., Scimeca J. M., Smith L. A., Robertson S. M. Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice. Curr. Eye Res. 8:1989;499-506.
24. Lausch R. N., Staats H., Oakes J. E., Cohen G. H., Eisenberg R. J. Prevention of herpes keratitis by monoclonal antibodies specific for discontinuous and continuous epitopes on glycoprotein D. Invest. Ophthalmol. Vis. Sci. 32:1991;2735-2740.
25. Leclerc C., Schutze M. P., Deriaud E., Przewlocki G. The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression. J. Immunol. 145:1990;1343-1349.
26. Liu T., Tang Q., Hendricks R. L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:1996;264-271.
27. Manickan E., Rouse B. T. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models. J. Virol. 69:1995;8178-8179.
28. Matloubian M., Concepcion R. J., Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:1994;8056-8063.
29. McLean C. S., Erturk M., Jennings R., Ni Challanain D., Minson A. C., Duncan I., Boursnell M. E. G., Inglis S. C. Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J. Infect. Dis. 170:1994;1100-1109.
30. McLean C. S., Ni Challanain D., Duncan I., Boursnell M. E. G., Jennings R., Inglis S. C. Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine. Vaccine. 14:1996;987-992.
31. Mester J. C., Rouse B. T. The mouse model and understanding immunity to herpes simplex virus. Rev. Infect. Dis. 13:1991;S935-S945.
32. Mishkin E. M., Blasiak M., Giorgio D., Ishizaka S. T. Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge. Viral Immunol. 5:1992;151-161.
33. Morrison L. A., Knipe D. M. Immunization with replication-defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68:1994;689-696.
34. Morrison L. A., Knipe D. M. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology. 320:1996;402-413.
35. ++. J. Gen. Virol. 68:1987;825-833.
36. Nash A. A., Phelan J., Wildy P. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J. Immunol. 126:1984;1260-1262.
37. Newell C. K., Martin S., Sendele D., Mercadal C. M., Rouse B. T. Herpes simplex virus-induced stromal keratitis: Role of T-lymphocyte subsets in immunopathology. J. Virol. 63:1989;769-775.
38. Nguyen L., Knipe D. M., Finberg R. W. Mechanism of virus-induced Ig subclass shifts. J. Immunol. 152:1994;478-484.
39. Nguyen L. H., Knipe D. M., Finberg R. W. Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J. Virol. 66:1992;7067-7072.
40. Niemialtowski M. G., Rouse B. T. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149:1992;3035-3039.
41. Pepose J. S. The relationship of corneal Langerhans cells to herpes simplex antigens during dendritic keratitis. Current Eye Research. 8:1989;851-858.
42. Posavad C. M., Koelle D. M., Corey L. High frequency of CD8(+) cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J. Virol. 70:1996;8165-8168.
43. Ranger A. M., Das M. P., Kuchroo V. K., Glimcher L. H. B7-2 (CD86) is essential for the development of IL-4-producing T cells. Int. Immunol. 8:1996;1549-1560.
44. Schultz K. R., Klarnet J. P., Gieni R. S., HayGlass K. T., Greenberg P. D. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia. Science. 249:1990;921-923.
45. Simmons A., Tscharke D. C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1992;1337-1344.
46. Staats H. F., Oakes J. E., Lausch R. N. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells. J. Virol. 65:1991;6008-6014.
47. Stewart J. A., Reef S. E., Pellett P. E., Corey L., Whitley R. J. Herpesvirus infections in persons infected with human immunodeficiency virus. Clinical Infectious Diseases. 21:1995;S114-20.
48. Tigges M. A., Koelle D., Karin H., Sekulovich R. E., Corey L., Burke R. L. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J. Virol. 66:1992;1622-1634.
49. Whitley R. J. Herpes simplex viruses. Virology. 1996;Lippincott-Raven Publishers, Philadelphia. p. 2297-2342.
50. Yasukawa M., Zarling J. M. Human cytotoxic T cell clones against herpes simplex virus infected cells. I. Lysis restricted by HLA class MB and DR antigens. J. Immunol. 133:1984;422-427.